Publication:
Autoimmunity plays a role in the onset of diabetes after 40 years of age.

dc.contributor.authorRolandsson, Olov
dc.contributor.authorHampe, Christiane S
dc.contributor.authorSharp, Stephen J
dc.contributor.authorArdanaz, Eva
dc.contributor.authorBoeing, Heiner
dc.contributor.authorFagherazzi, Guy
dc.contributor.authorMancini, Francesca Romana
dc.contributor.authorNilsson, Peter M
dc.contributor.authorOvervad, Kim
dc.contributor.authorChirlaque, Maria-Dolores
dc.contributor.authorDorronsoro, Miren
dc.contributor.authorGunter, Marc J
dc.contributor.authorKaaks, Rudolf
dc.contributor.authorKey, Timothy J
dc.contributor.authorKhaw, Kay-Tee
dc.contributor.authorKrogh, Vittorio
dc.contributor.authorKühn, Tilman
dc.contributor.authorPalli, Domenico
dc.contributor.authorPanico, Salvatore
dc.contributor.authorSacerdote, Carlotta
dc.contributor.authorSanchez-Perez, Maria-Jose
dc.contributor.authorSeveri, Gianluca
dc.contributor.authorSpijkerman, Annemieke M W
dc.contributor.authorTumino, Rosario
dc.contributor.authorvan der Schouw, Yvonne T
dc.contributor.authorRiboli, Elio
dc.contributor.authorForouhi, Nita G
dc.contributor.authorLangenberg, Claudia
dc.contributor.authorWareham, Nicholas J
dc.contributor.funderEU FP6 Programme
dc.contributor.funderNational Institutes of Health
dc.contributor.funderMedical Research Council
dc.contributor.funderNIHR Cambridge Biomedical Research Centre
dc.date.accessioned2023-02-08T14:37:23Z
dc.date.available2023-02-08T14:37:23Z
dc.date.issued2019-08-22
dc.description.abstractType 1 and type 2 diabetes differ with respect to pathophysiological factors such as beta cell function, insulin resistance and phenotypic appearance, but there may be overlap between the two forms of diabetes. However, there are relatively few prospective studies that have characterised the relationship between autoimmunity and incident diabetes. We investigated associations of antibodies against the 65 kDa isoform of GAD (GAD65) with type 1 diabetes and type 2 diabetes genetic risk scores and incident diabetes in adults in European Prospective Investigation into Cancer and Nutrition (EPIC)-InterAct, a case-cohort study nested in the EPIC cohort. GAD65 antibodies were analysed in EPIC participants (over 40 years of age and free of known diabetes at baseline) by radioligand binding assay in a random subcohort (n = 15,802) and in incident diabetes cases (n = 11,981). Type 1 diabetes and type 2 diabetes genetic risk scores were calculated. Associations between GAD65 antibodies and incident diabetes were estimated using Prentice-weighted Cox regression. GAD65 antibody positivity at baseline was associated with development of diabetes during a median follow-up time of 10.9 years (HR for GAD65 antibody positive vs negative 1.78; 95% CI 1.43, 2.20) after adjustment for sex, centre, physical activity, smoking status and education. The genetic risk score for type 1 diabetes but not type 2 diabetes was associated with GAD65 antibody positivity in both the subcohort (OR per SD genetic risk 1.24; 95% CI 1.03, 1.50) and incident cases (OR 1.97; 95% CI 1.72, 2.26) after adjusting for age and sex. The risk of incident diabetes in those in the top tertile of the type 1 diabetes genetic risk score who were also GAD65 antibody positive was 3.23 (95% CI 2.10, 4.97) compared with all other individuals, suggesting that 1.8% of incident diabetes in adults was attributable to this combination of risk factors. Our study indicates that incident diabetes in adults has an element of autoimmune aetiology. Thus, there might be a reason to re-evaluate the present subclassification of diabetes in adulthood.
dc.description.sponsorshipOpen access funding provided by Umea University. Funding for the InterAct project was provided by the EU FP6 Programme (grant number LSHM_CT_2006_037197). The autoantibody measurement was funded by Västerbotten County Council and Umeå University, Sweden (OR), the National Institutes of Health (DK26190) (CSH) and the Medical Research Council (MC_UU_12015/1) (NJW). OR: the Västerbotten County Council, Umeå University; MDC: Health Research Fund (FIS) of the Spanish Ministry of Health; Murcia Regional Government (N∫ 6236); EA: the Health Research Fund (FIS) of the Spanish Ministry of Health and Navarre Regional Government; RK: German Cancer Aid, the German Ministry of Research (BMBF); TJK: Cancer Research UK; KTK: the Medical Research Council UK, Cancer Research UK; PMN: the Swedish Research Council; KO: the Danish Cancer Society; SP: Compagnia di San Paolo; AMWS: the Dutch Ministry of Public Health, Welfare and Sports (VWS), the Netherlands Cancer Registry (NKR), LK Research Funds, Dutch Prevention Funds, Dutch ZON (Zorg Onderzoek Nederland), World Cancer Research Fund (WCRF), Statistics Netherlands; RT: AIRE-ONLUS Ragusa, AVIS-Ragusa, Sicilian Regional Government; AMWS: LK Research Funds, Dutch Prevention Funds, Dutch ZON (Zorg Onderzoek Nederland), World Cancer Research Fund (WCRF); YTvdS: verification of diabetes cases was additionally funded by NL Agency grant IGE05012 and an Incentive Grant from the Board of the UMC Utrecht, LK Research Funds, Dutch Prevention Funds; NGF: MRC core support (MC_UU_12015/5); NIHR Cambridge Biomedical Research Centre (IS-BRC-1215-20014). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.
dc.description.versionSi
dc.identifier.citationRolandsson O, Hampe CS, Sharp SJ, Ardanaz E, Boeing H, Fagherazzi G, et al. Autoimmunity plays a role in the onset of diabetes after 40 years of age. Diabetologia. 2020 Feb;63(2):266-277.
dc.identifier.doi10.1007/s00125-019-05016-3
dc.identifier.essn1432-0428
dc.identifier.pmcPMC6946728
dc.identifier.pmid31713011
dc.identifier.pubmedURLhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6946728/pdf
dc.identifier.unpaywallURLhttps://link.springer.com/content/pdf/10.1007/s00125-019-05016-3.pdf
dc.identifier.urihttp://hdl.handle.net/10668/14672
dc.issue.number2
dc.journal.titleDiabetologia
dc.journal.titleabbreviationDiabetologia
dc.language.isoen
dc.organizationEscuela Andaluza de Salud Pública-EASP
dc.organizationEscuela Andaluza de Salud Pública-EASP
dc.organizationInstituto de Investigación Biosanitaria de Granada (ibs.GRANADA)
dc.page.number266-277
dc.publisherSpringer
dc.pubmedtypeJournal Article
dc.pubmedtypeResearch Support, N.I.H., Extramural
dc.pubmedtypeResearch Support, Non-U.S. Gov't
dc.relation.projectIDLSHM_CT_2006_037197
dc.relation.projectIDDK26190
dc.relation.projectIDMC_UU_12015/1
dc.relation.projectIDIS-BRC-1215-20014
dc.relation.publisherversionhttps://doi.org/10.1007/s00125-019-05016-3
dc.rightsAttribution 4.0 International
dc.rights.accessRightsopen access
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.subjectAutoantibody
dc.subjectAutoimmunity
dc.subjectGenetic risk score
dc.subjectIncident diabetes
dc.subjectType 1 diabetes
dc.subjectType 2 diabetes
dc.subject.decsAdulto
dc.subject.decsAnciano
dc.subject.decsAnticuerpos
dc.subject.decsAutoinmunidad
dc.subject.decsDiabetes Mellitus Tipo 1
dc.subject.decsDiabetes Mellitus Tipo 2
dc.subject.decsEstudios de casos y controles
dc.subject.decsFemenino
dc.subject.decsGlutamato descarboxilasa
dc.subject.decsHumanos
dc.subject.decsPersona de mediana edad
dc.subject.meshAdult
dc.subject.meshAged
dc.subject.meshAntibodies
dc.subject.meshAutoimmunity
dc.subject.meshCase-Control Studies
dc.subject.meshDiabetes Mellitus, Type 1
dc.subject.meshDiabetes Mellitus, Type 2
dc.subject.meshFemale
dc.subject.meshGlutamate Decarboxylase
dc.subject.meshHumans
dc.subject.meshMale
dc.subject.meshMiddle Aged
dc.titleAutoimmunity plays a role in the onset of diabetes after 40 years of age.
dc.typeresearch article
dc.type.hasVersionVoR
dc.volume.number63
dspace.entity.typePublication

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
PMC6946728.pdf
Size:
778.21 KB
Format:
Adobe Portable Document Format